What is it about?
This study investigates the potential of cold atmospheric plasma (CAP) as a treatment for cholangiocarcinoma (CCA), an aggressive and rare liver cancer with limited treatment options. We examined the molecular mechanisms behind CAP's antitumor effects in both in vivo and in vitro models of CCA. CAP treatment led to DNA damage, cell cycle arrest, and tumor cell apoptosis in these models, as well as changes in the tumor microenvironment related to macrophage polarization.
Featured Image
Photo by Louis Reed on Unsplash
Why is it important?
This work is important because it demonstrates the potential of CAP as a novel therapeutic option for cholangiocarcinoma, a cancer with few effective treatments. By identifying the molecular mechanisms underlying CAP's antitumor effects, the study provides a foundation for further research into the potential benefits of this therapy. Developing new, effective treatments for CCA is crucial to improve patient outcomes and overall survival rates.
Perspectives
Read the Original
This page is a summary of: Cold-Atmospheric Plasma Induces Tumor Cell Death in Preclinical In Vivo and In Vitro Models of Human Cholangiocarcinoma, Cancers, May 2020, MDPI AG,
DOI: 10.3390/cancers12051280.
You can read the full text:
Contributors
The following have contributed to this page